Yilong Ma

10.0k total citations · 4 hit papers
129 papers, 7.5k citations indexed

About

Yilong Ma is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Yilong Ma has authored 129 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Neurology, 45 papers in Cellular and Molecular Neuroscience and 37 papers in Cognitive Neuroscience. Recurrent topics in Yilong Ma's work include Neurological disorders and treatments (65 papers), Parkinson's Disease Mechanisms and Treatments (61 papers) and Functional Brain Connectivity Studies (31 papers). Yilong Ma is often cited by papers focused on Neurological disorders and treatments (65 papers), Parkinson's Disease Mechanisms and Treatments (61 papers) and Functional Brain Connectivity Studies (31 papers). Yilong Ma collaborates with scholars based in United States, Canada and China. Yilong Ma's co-authors include David Eidelberg, Vijay Dhawan, Alan C. Evans, Olivier Rousset, Andrew Feigin, Chengke Tang, Phoebe G. Spetsieris, Shichun Peng, Thomas Chaly and Chris C. Tang and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Yilong Ma

126 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cocaine Cues and Dopamine in Dorsal Striatum: Mechanism of Craving in Cocaine Addiction

2006 868 citations Yilong Ma et al. Journal of Neuroscience profile →
Correction for partial volume effects in PET: principle and validation.

1998 741 citations Olivier Rousset, Yilong Ma et al. profile →
The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease

2022 186 citations Yilong Ma, Shichun Peng et al. profile →
Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease

2025 25 citations Viviane Tabar, Harini Sarva et al. Nature profile →

Peers

Countries citing papers authored by Yilong Ma

Since Specialization

Citations

This map shows the geographic impact of Yilong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yilong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yilong Ma more than expected).

Fields of papers citing papers by Yilong Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yilong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yilong Ma. The network helps show where Yilong Ma may publish in the future.

Co-authorship network of co-authors of Yilong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Yilong Ma. A scholar is included among the top collaborators of Yilong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yilong Ma. Yilong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease breakdown → 2025 ·Nature ·Viviane Tabar, Harini Sarva, Andrés M. Lozano, Alfonso Fasano, Suneil K. Kalia, Kenny Kwok Hei Yu, Cameron Brennan, Yilong Ma, Shichun Peng, David Eidelberg, (unknown), Stefan Irion, (unknown), N. Abid, Antoine Lampron, Lorenz Studer, Claire Henchcliffe	25
2	Positron Emission Tomography Imaging in Clinical Trials for Parkinson's Disease: Applications of Metabolic Brain Network Approach 2025 ·Movement Disorders ·Vijay Dhawan, Shichun Peng, Phoebe G. Spetsieris, David Eidelberg, Yilong Ma	0
3	Differential associations of APOE and TREM2 variants with glial fibrillary acidic protein and neurofilament light in plasma of UK Biobank participants support distinct disease mechanisms 2025 ·Molecular Psychiatry ·Yun Freudenberg‐Hua, Luca Giliberto, Cristina d’Abramo, Wentian Li, Yilong Ma, Alison Goate, Jeremy Koppel	1
4	Longitudinal network changes and phenoconversion risk in isolated REM sleep behavior disorder 2024 ·Nature Communications ·Chris C. Tang, Yoshikazu Nakano, An Vo, Nha Nguyen, Katharina A. Schindlbeck, Paul J. Mattis, Kathleen L. Poston, Jean‐François Gagnon, Ronald B. Postuma, Martin Niethammer, Yilong Ma, Shichun Peng, Vijay Dhawan, David Eidelberg	4
5	A Network Imaging Biomarker of X‐Linked Dystonia‐Parkinsonism 2023 ·Annals of Neurology ·Martin Niethammer, Chris C. Tang, Roland Dominic G. Jamora, An Vo, Nha Nguyen, Yilong Ma, Shichun Peng, Jeff L. Waugh, Ana Westenberger, David Eidelberg	3
6	Brain Functional and Structural Signatures in Parkinson’s Disease 2020 ·Frontiers in Aging Neuroscience ·Chunhua Liu, Jiehui Jiang, (unknown), Hucheng Zhou, Huiwei Zhang, Min Wang, (unknown), (unknown), Ping Wu, Jingjie Ge, Jian Wang, Yilong Ma, Chuantao Zuo	7
7	Validation of the Alzheimer’s dementia conversion-related pattern as a biomarker of neurodegeneration within the NIA-AA research framework 2020 ·Nuklearmedizin - NuclearMedicine ·Ganna Blazhenets, Lars Frings, Yilong Ma, A Sörensen, David Eidelberg, (unknown)	0
8	Reproducible network and regional topographies of abnormal glucose metabolism associated with progressive supranuclear palsy: Multivariate and univariate analyses in American and Chinese patient cohorts 2018 ·Human Brain Mapping ·Jingjie Ge, Jian Wu, Shichun Peng, Ping Wu, Jian Wang, Huiwei Zhang, Yihui Guan, David Eidelberg, Chuantao Zuo, Yilong Ma	33
9	The Age-Related Perfusion Pattern Measured With Arterial Spin Labeling MRI in Healthy Subjects 2018 ·Frontiers in Aging Neuroscience ·Nan Zhang, Marc L. Gordon, Yilong Ma, (unknown), Jesús J. Gomar, Shichun Peng, Peter B. Kingsley, David Eidelberg, Terry E. Goldberg	48
10	Increased putamen hypercapnic vasoreactivity in levodopa-induced dyskinesia 2017 ·JCI Insight ·(unknown), Katharina A. Schindlbeck, Chris C. Tang, Martin Niethammer, Yoon Young Choi, (unknown), Amir Nazem, Dominic J. Nardi, (unknown), Andrew Feigin, Yilong Ma, Shichun Peng, Vijay Dhawan, David Eidelberg	16
11	Abnormal metabolic network activity in REM sleep behavior disorder 2014 ·Neurology ·Florian Holtbernd, Jean‐François Gagnon, Ron B. Postuma, Yilong Ma, Chris C. Tang, Andrew Feigin, Vijay Dhawan, Mélanie Vendette, Jean‐Paul Soucy, David Eidelberg, Jacques Montplaisir	137
12	The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging 2014 ·Psychiatry Research Neuroimaging ·Christopher M. Marano, Clifford I. Workman, Christopher H. Lyman, Elisse Kramer, (unknown), Yilong Ma, Vijay Dhawan, Thomas Chaly, David Eidelberg, Gwenn S. Smith	23
13	Metabolic network as a progression biomarker of premanifest Huntington’s disease 2013 ·Journal of Clinical Investigation ·Chris C. Tang, Andrew Feigin, Yilong Ma, Christian Habeck, Jane S. Paulsen, Klaus L. Leenders, Laura K. Teune, Joost C.H. van Oostrom, Mark Guttman, Vijay Dhawan, David Eidelberg	86
14	Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data 2013 ·Journal of Visualized Experiments ·Phoebe G. Spetsieris, Yilong Ma, Shichun Peng, Ji Hyun Ko, Vijay Dhawan, Chris C. Tang, David Eidelberg	62
15	Parkinson's disease cognitive network correlates with caudate dopamine 2013 ·NeuroImage ·Martin Niethammer, Chris C. Tang, Yilong Ma, Paul J. Mattis, Ji Hyun Ko, Vijay Dhawan, David Eidelberg	77
16	Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects 2010 ·NeuroImage ·Hideo Mure, Shigeki Hirano, Chris C. Tang, Ioannis U. Isaias, Angelo Antonini, Yilong Ma, Vijay Dhawan, David Eidelberg	192
17	The functional neuroanatomy of geriatric depression 2009 ·International Journal of Geriatric Psychiatry ·Gwenn S. Smith, Elisse Kramer, Yilong Ma, Peter B. Kingsley, Vijay Dhawan, Thomas Chaly, David Eidelberg	73
18	Dissociation of Metabolic and Neurovascular Responses to Levodopa in the Treatment of Parkinson's Disease 2008 ·Journal of Neuroscience ·Shigeki Hirano, Kotaro Asanuma, Yilong Ma, Chengke Tang, Andrew Feigin, Vijay Dhawan, Maren Carbon, David Eidelberg	117
19	Correction for partial volume effects in PET using MRI-based 3-D simulations of individual human brain metabolism 1993 ·Annals of Nuclear Medicine ·Olivier Rousset, Yilong Ma, Gabriel C. Léger, Albert Gjedde, Alan C. Evans	22
20	3D simulation of pet brain images using segmented MRI data and positron tomograph characteristics 1993 ·Computerized Medical Imaging and Graphics ·Yilong Ma, Micheline Kamber, Alan C. Evans	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact